AXIM Biotechnologies, Inc. operates as a biotechnology company. It focuses in the research, development and production of pharmaceutical, nutraceutical, cosmetic and genetically controlled botanical products. The firm also involves in the extraction and purification of cannabinoids technologies based on its proprietary technologies. Its products include CBD-based controlled release chewing gum under CanChew brand and a combination of CBD and THC gum that treats pain and spasticity associated with multiple sclerosis under MedChew Rx brand. The company was founded on November 18, 2010 and is headquartered in San Diego, CA.